Yonhap Infomax NewsDrug developers Canaphtherapeutics and IM Biologics set to debut on KOSDAQ this week with IPO prices at top of indicative ranges following strong investor demand, while three companies open public subscriptions including precision cooling tech firm Licensemedical
#YonhapInfomax #Canaphtherapeutics #IMBiologics #KOSDAQListing #IPOSubscription #BookBuilding #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=109979
#YonhapInfomax #Canaphtherapeutics #IMBiologics #KOSDAQListing #IPOSubscription #BookBuilding #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=109979
Canaphtherapeutics, IM Biologics to List on KOSDAQ This Week; Three IPO Subscriptions Open
Drug developers Canaphtherapeutics and IM Biologics set to debut on KOSDAQ this week with IPO prices at top of indicative ranges following strong investor demand, while three companies open public subscriptions including precision cooling tech firm Licensemedical